Literature DB >> 2162159

Molecular cloning of feline leukemia provirus genomes integrated in the feline large granular lymphoma cells.

Y Matsumoto1, H Tsujimoto, M Fukasawa, Y Hirota, T Miura, M Hayami, R Goitsuka, K Ono, A Hasegawa.   

Abstract

Feline leukemia virus (FeLV) is a horizontally transmitted agent of the domestic cat which is known to be associated with wide spectrum of diseases of the hematopoietic system. In the present study, proviral DNAs of FeLV proviruses were examined in the tumor cells of natural killer cell lineage which is very rare in cats. In the chromosomal DNA of the tumor cells, 5 distinct bands corresponding to exogenous FeLV provirus genomes were detected by digestion with EcoRI which does not cut most FeLV isolates. Five clones of pLC1, pLC2, pLC3, pLC4, and pLC5 obtained from the 5 respective bands were analysed by restriction endonuclease mapping and Southern blot hybridization using gene-specific probes of FeLV. The results have clearly demonstrated that pLC4 and pLC5 contained large deletions in the pol and part of gag regions, while the full-length proviruses could be observed in pLC1 and pLC2. Furthermore, pLC3 contained part of a variant FeLV genome having an EcoRI site in its gag region. The molecular clones of defective and variant FeLV in this study may be useful for the further examination of tumorigenesis of large granular lymphoma in the cat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162159     DOI: 10.1007/BF01311052

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

1.  Structural abnormality and over-expression of the myc gene in feline leukemias.

Authors:  T Miura; H Tsujimoto; M Fukasawa; T Kodama; M Shibuya; A Hasegawa; M Hayami
Journal:  Int J Cancer       Date:  1987-10-15       Impact factor: 7.396

2.  Horizontal transmission of leukemia virus and leukemia in the cat.

Authors:  W Jarrett; O Jarrett; L Mackey; H Laird; W Hardy; M Essex
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

3.  Selective effect of feline leukaemia virus on early erythroid precursors.

Authors:  D Onions; O Jarrett; N Testa; F Frassoni; S Toth
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

4.  Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias.

Authors:  J C Neil; D Hughes; R McFarlane; N M Wilkie; D E Onions; G Lees; O Jarrett
Journal:  Nature       Date:  1984 Apr 26-May 2       Impact factor: 49.962

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Molecular cloning of a feline leukemia provirus integrated adjacent to the c-myc gene in a feline T-cell leukemia cell line and the unique structure of its long terminal repeat.

Authors:  T Miura; M Shibuya; H Tsujimoto; M Fukasawa; M Hayami
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

7.  Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus.

Authors:  C J Sherr; L A Fedele; M Oskarsson; J Maizel; G Vande Woude
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats.

Authors:  J W Casey; A Roach; J I Mullins; K B Burck; M O Nicolson; M B Gardner; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Pathogenic and host range determinants of the feline aplastic anemia retrovirus.

Authors:  N Riedel; E A Hoover; R E Dornsife; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells.

Authors:  N Kobayashi; H Konishi; H Sabe; K Shigesada; T Noma; T Honjo; M Hatanaka
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.